Shanghai Pharmaceuticals Holding Co Ltd (601607) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Pharmaceuticals Holding Co Ltd (601607) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.56 Billion ≈ $227.99 Million USD) by net assets (CN¥89.62 Billion ≈ $13.11 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shanghai Pharmaceuticals Holding Co Ltd (601607) defensive interval to measure how many days the company can operate on defensive assets alone.
Shanghai Pharmaceuticals Holding Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Shanghai Pharmaceuticals Holding Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shanghai Pharmaceuticals Holding Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Pharmaceuticals Holding Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Noble Corporation plc
NYSE:NE
|
0.061x |
|
Osisko Gold Ro
TO:OR
|
0.059x |
|
Glaukos Corp
NYSE:GKOS
|
-0.019x |
|
Cencosud
SN:CENCOSUD
|
0.007x |
|
Light & Wonder Inc
NASDAQ:LNW
|
0.254x |
|
Unicaja Banco SA
MC:UNI
|
0.006x |
|
InterDigital Inc
NASDAQ:IDCC
|
0.015x |
|
Bank of Maharashtra
NSE:MAHABANK
|
-0.678x |
Annual Cash Flow Conversion Efficiency for Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Shanghai Pharmaceuticals Holding Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Shanghai Pharmaceuticals Holding Co Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥89.79 Billion ≈ $13.14 Billion |
CN¥6.15 Billion ≈ $900.55 Million |
0.069x | -1.50% |
| 2024-12-31 | CN¥83.74 Billion ≈ $12.25 Billion |
CN¥5.83 Billion ≈ $852.71 Million |
0.070x | +6.84% |
| 2023-12-31 | CN¥80.33 Billion ≈ $11.75 Billion |
CN¥5.23 Billion ≈ $765.54 Million |
0.065x | +7.10% |
| 2022-12-31 | CN¥78.00 Billion ≈ $11.41 Billion |
CN¥4.74 Billion ≈ $694.10 Million |
0.061x | -29.03% |
| 2021-12-31 | CN¥59.07 Billion ≈ $8.64 Billion |
CN¥5.06 Billion ≈ $740.63 Million |
0.086x | -31.47% |
| 2020-12-31 | CN¥54.74 Billion ≈ $8.01 Billion |
CN¥6.84 Billion ≈ $1.00 Billion |
0.125x | +2.54% |
| 2019-12-31 | CN¥49.39 Billion ≈ $7.23 Billion |
CN¥6.02 Billion ≈ $881.26 Million |
0.122x | +80.61% |
| 2018-12-31 | CN¥46.43 Billion ≈ $6.79 Billion |
CN¥3.14 Billion ≈ $458.77 Million |
0.068x | +1.13% |
| 2017-12-31 | CN¥39.68 Billion ≈ $5.81 Billion |
CN¥2.65 Billion ≈ $387.60 Million |
0.067x | +26.32% |
| 2016-12-31 | CN¥36.83 Billion ≈ $5.39 Billion |
CN¥1.95 Billion ≈ $284.86 Million |
0.053x | +32.43% |
| 2015-12-31 | CN¥33.81 Billion ≈ $4.95 Billion |
CN¥1.35 Billion ≈ $197.42 Million |
0.040x | -7.08% |
| 2014-12-31 | CN¥31.10 Billion ≈ $4.55 Billion |
CN¥1.34 Billion ≈ $195.45 Million |
0.043x | +27.95% |
| 2013-12-31 | CN¥29.00 Billion ≈ $4.24 Billion |
CN¥973.45 Million ≈ $142.45 Million |
0.034x | -19.20% |
| 2012-12-31 | CN¥27.70 Billion ≈ $4.05 Billion |
CN¥1.15 Billion ≈ $168.39 Million |
0.042x | -39.10% |
| 2011-12-31 | CN¥25.98 Billion ≈ $3.80 Billion |
CN¥1.77 Billion ≈ $259.36 Million |
0.068x | -51.92% |
| 2010-12-31 | CN¥11.88 Billion ≈ $1.74 Billion |
CN¥1.69 Billion ≈ $246.73 Million |
0.142x | -50.39% |
| 2009-12-31 | CN¥2.32 Billion ≈ $339.84 Million |
CN¥664.13 Million ≈ $97.18 Million |
0.286x | +109.19% |
| 2008-12-31 | CN¥2.09 Billion ≈ $305.80 Million |
CN¥285.68 Million ≈ $41.80 Million |
0.137x | -45.25% |
| 2007-12-31 | CN¥1.96 Billion ≈ $286.56 Million |
CN¥488.94 Million ≈ $71.55 Million |
0.250x | -11.50% |
| 2006-12-31 | CN¥2.07 Billion ≈ $302.45 Million |
CN¥583.11 Million ≈ $85.33 Million |
0.282x | +675.17% |
| 2005-12-31 | CN¥2.01 Billion ≈ $293.52 Million |
CN¥73.00 Million ≈ $10.68 Million |
0.036x | +21.65% |
| 2004-12-31 | CN¥2.06 Billion ≈ $301.60 Million |
CN¥61.66 Million ≈ $9.02 Million |
0.030x | +13043.04% |
| 2003-12-31 | CN¥2.13 Billion ≈ $311.31 Million |
CN¥484.27K ≈ $70.86K |
0.000x | -99.55% |
| 2002-12-31 | CN¥2.00 Billion ≈ $292.60 Million |
CN¥100.84 Million ≈ $14.76 Million |
0.050x | +39.50% |
| 2001-12-31 | CN¥1.82 Billion ≈ $266.06 Million |
CN¥65.73 Million ≈ $9.62 Million |
0.036x | -75.64% |
| 2000-12-31 | CN¥985.30 Million ≈ $144.18 Million |
CN¥146.22 Million ≈ $21.40 Million |
0.148x | -23.41% |
| 1999-12-31 | CN¥849.92 Million ≈ $124.37 Million |
CN¥164.67 Million ≈ $24.10 Million |
0.194x | +148.82% |
| 1998-12-31 | CN¥713.42 Million ≈ $104.40 Million |
CN¥-283.14 Million ≈ $-41.43 Million |
-0.397x | -- |
About Shanghai Pharmaceuticals Holding Co Ltd
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric … Read more